Feb 012022
Drug Name |
Active Ingredient(s) |
Approval Date |
FDA-Approved Use on Approval Date |
Press Release |
Drug Trials Snapshot |
| Vabysmo | faricimab-svoa | 1/28/2022 | To treat neovascular (wet) aged-related macular degeneration and diabetic macular edema | Drug Trials Snapshot | |
| Kimmtrak | tebentafusp-tebn | 1/25/2022 | To treat unresectable or metastatic uveal melanoma | Drug Trials Snapshot | |
| Cibinqo | abrocitinib | 1/14/2022 | To treat refractory, moderate-to-severe atopic dermatitis | Drug Trials Snapshot | |
| Quviviq | daridorexant | 1/7/2022 | To treat insomnia | Drug Trials Snapshot |
Sorry, the comment form is closed at this time.